Increased Levels of Oxidative Stress Markers, Soluble CD40 Ligand, and Carotid Intima-Media Thickness Reflect Acceleration of Atherosclerosis in Male Patients with Ankylosing Spondylitis in Active Phase and without the Classical Cardiovascular Risk Factors
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Increased Levels of Oxidative Stress Markers, Soluble CD40 Ligand, and Carotid Intima-Media Thickness Reflect Acceleration of Atherosclerosis in Male Patients with Ankylosing Spondylitis in Active Phase and without the Classical Cardiovascular Risk Factors
Authors
Keywords
-
Journal
Oxidative Medicine and Cellular Longevity
Volume 2017, Issue -, Pages 1-8
Publisher
Hindawi Limited
Online
2017-08-15
DOI
10.1155/2017/9712536
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Is ankylosing spondylitis a risk factor for cardiovascular disease, and how do these risks compare with those in rheumatoid arthritis?
- (2016) Jonas K Eriksson et al. ANNALS OF THE RHEUMATIC DISEASES
- Atherosclerotic cardiovascular disease in patients with chronic inflammatory joint disorders
- (2016) R Agca et al. HEART
- The LDL/HDL ratio and atherosclerosis in ankylosing spondylitis
- (2016) A. Kucuk et al. ZEITSCHRIFT FUR RHEUMATOLOGIE
- Cardiovascular risk management in patients with active Ankylosing Spondylitis: a detailed evaluation
- (2015) Sjoerd C Heslinga et al. BMC MUSCULOSKELETAL DISORDERS
- Soluble CD40 Ligand Promotes Macrophage Foam Cell Formation in the Etiology of Atherosclerosis
- (2015) Ming Yuan et al. CARDIOLOGY
- Vascular oxidative stress, nitric oxide and atherosclerosis
- (2014) Huige Li et al. ATHEROSCLEROSIS
- Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal
- (2014) Antonio Ayala et al. Oxidative Medicine and Cellular Longevity
- Triglyceride to HDL-C Ratio and Increased Arterial Stiffness in Children, Adolescents, and Young Adults
- (2013) E. M. Urbina et al. PEDIATRICS
- Global prevalence of ankylosing spondylitis
- (2013) L. E. Dean et al. RHEUMATOLOGY
- β2-glycoprotein I and oxidative inflammation in early atherogenesis: A progression from innate to adaptive immunity?
- (2012) Eiji Matsuura et al. AUTOIMMUNITY REVIEWS
- Levels of lipid peroxidation and antioxidant vitamins in plasma and erythrocytes of patients with ankylosing spondylitis
- (2011) Mustafa Nazıroğlu et al. CLINICAL BIOCHEMISTRY
- Assessment of Subclinical Vascular Disease Associated with Ankylosing Spondylitis
- (2011) N. BODNAR et al. JOURNAL OF RHEUMATOLOGY
- Decrease in antioxidant status of plasma and erythrocytes from patients with ankylosing spondylitis
- (2010) Agata Stanek et al. CLINICAL BIOCHEMISTRY
- Cardiovascular profile in ankylosing spondylitis: A systematic review and meta-analysis
- (2010) Sylvain Mathieu et al. ARTHRITIS CARE & RESEARCH
- Population-based estimates of common comorbidities and cardiovascular disease in ankylosing spondylitis
- (2010) Ann Bremander et al. ARTHRITIS CARE & RESEARCH
- Usefulness of Triglycerides-to–High-Density Lipoprotein Cholesterol Ratio for Predicting the First Coronary Event in Men
- (2009) Alberto Cordero et al. AMERICAN JOURNAL OF CARDIOLOGY
- Immune and Inflammatory Mechanisms of Atherosclerosis
- (2009) Elena Galkina et al. Annual Review of Immunology
- Short-term delivery of anti-PlGF antibody delays progression of atherosclerotic plaques to vulnerable lesions
- (2009) C. Roncal et al. CARDIOVASCULAR RESEARCH
- Inflammation in Atherosclerosis
- (2009) Peter Libby et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Evaluation of inflammation and oxidative stress in ankylosing spondylitis: a role for macrophage migration inhibitory factor
- (2009) Leyla Didem Kozaci et al. Modern Rheumatology
- Uricase based methods for determination of uric acid in serum
- (2008) Yunsheng Zhao et al. MICROCHIMICA ACTA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started